TuHURA Biosciences (HURA) Competitors $4.99 +0.07 (+1.42%) Closing price 01/31/2025 04:00 PM EasternExtended Trading$4.85 -0.14 (-2.81%) As of 01/31/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends HURA vs. SEPN, LENZ, PLRX, IMTX, DNA, VERV, CRGX, OPT, ABUS, and DNTHShould you be buying TuHURA Biosciences stock or one of its competitors? The main competitors of TuHURA Biosciences include Septerna (SEPN), LENZ Therapeutics (LENZ), Pliant Therapeutics (PLRX), Immatics (IMTX), Ginkgo Bioworks (DNA), Verve Therapeutics (VERV), CARGO Therapeutics (CRGX), Opthea (OPT), Arbutus Biopharma (ABUS), and Dianthus Therapeutics (DNTH). These companies are all part of the "pharmaceutical products" industry. TuHURA Biosciences vs. Septerna LENZ Therapeutics Pliant Therapeutics Immatics Ginkgo Bioworks Verve Therapeutics CARGO Therapeutics Opthea Arbutus Biopharma Dianthus Therapeutics Septerna (NASDAQ:SEPN) and TuHURA Biosciences (NASDAQ:HURA) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, community ranking, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations. Is SEPN or HURA more profitable? Company Net Margins Return on Equity Return on Assets SepternaN/A N/A N/A TuHURA Biosciences N/A N/A -152.88% Which has better valuation & earnings, SEPN or HURA? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSepternaN/AN/AN/AN/AN/ATuHURA BiosciencesN/AN/A-$8.32MN/AN/A Does the MarketBeat Community believe in SEPN or HURA? Septerna received 2 more outperform votes than TuHURA Biosciences when rated by MarketBeat users. CompanyUnderperformOutperformSepternaOutperform Votes4100.00% Underperform VotesNo VotesTuHURA BiosciencesOutperform Votes2100.00% Underperform VotesNo Votes Do analysts rate SEPN or HURA? Septerna presently has a consensus price target of $43.67, suggesting a potential upside of 158.23%. TuHURA Biosciences has a consensus price target of $13.00, suggesting a potential upside of 160.52%. Given TuHURA Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe TuHURA Biosciences is more favorable than Septerna.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Septerna 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00TuHURA Biosciences 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Do institutionals and insiders hold more shares of SEPN or HURA? 0.6% of TuHURA Biosciences shares are owned by institutional investors. 0.2% of TuHURA Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media favor SEPN or HURA? In the previous week, Septerna had 3 more articles in the media than TuHURA Biosciences. MarketBeat recorded 5 mentions for Septerna and 2 mentions for TuHURA Biosciences. Septerna's average media sentiment score of 0.74 beat TuHURA Biosciences' score of 0.62 indicating that Septerna is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Septerna 1 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive TuHURA Biosciences 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummarySepterna and TuHURA Biosciences tied by winning 5 of the 10 factors compared between the two stocks. Get TuHURA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HURA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HURA vs. The Competition Export to ExcelMetricTuHURA BiosciencesPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$213.54M$6.87B$5.57B$9.14BDividend YieldN/A2.90%5.31%3.99%P/E RatioN/A4.4258.4413.87Price / SalesN/A321.141,257.3981.09Price / CashN/A73.5045.9637.70Price / Book-1.215.275.124.71Net Income-$8.32M$136.98M$111.17M$224.24M7 Day Performance14.45%-0.59%2.38%-0.17%1 Month Performance22.00%0.18%3.20%0.60%1 Year PerformanceN/A7.68%24.70%20.43% TuHURA Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HURATuHURA BiosciencesN/A$4.99+1.4%$13.00+160.5%N/A$213.54MN/A0.00N/ANews CoverageSEPNSepternaN/A$15.91-13.9%$43.67+174.5%N/A$710.62MN/A0.00N/ALENZLENZ Therapeutics1.9687 of 5 stars$24.69+0.5%$35.40+43.4%N/A$678.98MN/A0.00110Upcoming EarningsAnalyst RevisionNews CoveragePLRXPliant Therapeutics3.901 of 5 stars$11.08+1.5%$40.50+265.5%-40.0%$671.85M$1.58M-3.3190IMTXImmatics1.446 of 5 stars$5.54-1.1%$16.67+201.1%-51.8%$662.33M$58.44M-8.41260Short Interest ↑DNAGinkgo Bioworks0.6449 of 5 stars$11.52-10.2%$4.58-60.3%N/A$661.93M$217.11M-0.881,218News CoverageVERVVerve Therapeutics2.2924 of 5 stars$7.68-2.9%$25.75+235.3%-29.7%$650.19M$11.76M-3.12110CRGXCARGO Therapeutics2.7575 of 5 stars$13.94+3.6%$31.80+128.1%-83.6%$641.43MN/A-3.27116Analyst DowngradeAnalyst RevisionNews CoverageOPTOpthea2.6974 of 5 stars$4.69-4.1%$12.00+155.9%+105.2%$640.95M$120,000.000.008Analyst ForecastShort Interest ↑News CoverageGap UpABUSArbutus Biopharma2.7053 of 5 stars$3.38+1.8%$5.50+62.7%+40.5%$640.48M$18.14M-7.8690Positive NewsDNTHDianthus Therapeutics1.9478 of 5 stars$21.62+1.9%$46.43+114.7%+16.6%$639.69M$2.83M-8.6480Short Interest ↑ Related Companies and Tools Related Companies SEPN Competitors LENZ Competitors PLRX Competitors IMTX Competitors DNA Competitors VERV Competitors CRGX Competitors OPT Competitors ABUS Competitors DNTH Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HURA) was last updated on 2/1/2025 by MarketBeat.com Staff From Our PartnersElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredWill DeepSeek pop the AI bubble?An overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump vs. TexasEver since Donald Trump won the election, U.S. states have been rushing to pass new currency rules. These r...Stansberry Research | SponsoredTurning Panic Into OpportunityAI stocks were hammered on Jan. 27. That includes Nvidia, the undisputed leader in the artificial intellige...Weiss Ratings | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredNew catalyst on Wall Street’s radar for this week (NOT Trump)Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger ...Timothy Sykes | SponsoredWill Elon trigger another AI flash crash?AI continues to dominate financial headlines in 2025...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TuHURA Biosciences Please log in to your account or sign up in order to add this asset to your watchlist. Share TuHURA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HURA Stock Alerts